4-(3-카르복시-피리딘-2-일)-피페라진-1-카르복시산tert-부틸에스테르

4-(3-카르복시-피리딘-2-일)-피페라진-1-카르복시산tert-부틸에스테르
4-(3-카르복시-피리딘-2-일)-피페라진-1-카르복시산tert-부틸에스테르 구조식 이미지
카스 번호:
902835-85-2
한글명:
4-(3-카르복시-피리딘-2-일)-피페라진-1-카르복시산tert-부틸에스테르
동의어(한글):
4-(3-카르복시-피리딘-2-일)-피페라진-1-카르복시산tert-부틸에스테르
상품명:
4-(3-CARBOXY-PYRIDIN-2-YL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
동의어(영문):
2-(4-BOC-PIPERAZIN-1-YL)NICOTINIC ACID;2-(1-Boc-piperazin-4-yl)-pyridine-3-carboxylic acid;4-(3-Carboxypyridin-2-yl)piperazine, N1-BOC protected;2-(4-(tert-butoxycarbonyl)piperazin-1-yl)nicotinic acid;2-{4-[(tert-butoxy)carbonyl]piperazin-1-yl}pyridine-3-carboxylic acid;4-(3-CARBOXY-PYRIDIN-2-YL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER;1-Piperazinecarboxylic acid, 4-(3-carboxy-2-pyridinyl)-, 1-(1,1-dimethylethyl) e…;4-(3-Carboxy-pyridin-2-yl)piperazine-1-carboxylic acidtert-butyl ester≥ 99% (HPLC);1-Piperazinecarboxylic acid, 4-(3-carboxy-2-pyridinyl)-, 1-(1,1-dimethylethyl) ester
CBNumber:
CB8235442
분자식:
C15H21N3O4
포뮬러 무게:
307.34
MOL 파일:
902835-85-2.mol

4-(3-카르복시-피리딘-2-일)-피페라진-1-카르복시산tert-부틸에스테르 속성

안전

위험품 표기 T
HS 번호 2933599590

4-(3-카르복시-피리딘-2-일)-피페라진-1-카르복시산tert-부틸에스테르 C화학적 특성, 용도, 생산

화학적 성질

White powder

4-(3-카르복시-피리딘-2-일)-피페라진-1-카르복시산tert-부틸에스테르 준비 용품 및 원자재

원자재

준비 용품


4-(3-카르복시-피리딘-2-일)-피페라진-1-카르복시산tert-부틸에스테르 공급 업체

글로벌( 15)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Amadis Chemical Company Limited
571-89925085
sales@amadischem.com China 131980 58
Chemsky(shanghai)International Co.,Ltd. 021-50135380
shchemsky@sina.com China 32344 50
Amatek Scientific Co. Ltd. 0512-56316828
info@amateksci.com China 28818 58
Yujinpharma(Tianjin) Technology Co.,Ltd. 13370351217 kungfu1217@1
kungfu1217@163.com China 9196 58
Jiangsu aikang biomedical research and development co., LTD 025-66110311 13155353615
qzhang@aikonchem.com China 15527 58
Changzhou Kechem Bio-Scientific Co., LTD. 0519-68985668 13685222090
sales@kechem.cn China 26033 58
United States Biological --
sales@advtechind.com United States 6106 58
Carbosynth --
sales@carbosynth.com United Kingdom 6018 58

Copyright 2019 © ChemicalBook. All rights reserved